Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-25-044863
Filing Date
2025-05-16
Accepted
2025-05-16 16:01:24
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 11292
2 AGREEMENT OF THE REPORTING PERSONS, DATED MAY 16, 2025 ea024252801ex99-1_cuebio.htm EX-99.1 8808
  Complete submission text file 0001213900-25-044863.txt   21607
Mailing Address 100 WILSHIRE BLVD 15TH FL SANTA MONICA CA 90401
Business Address
STROME MARK E (Filed by) CIK: 0000919484 (see all company filings)

Type: SCHEDULE 13G/A

Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Subject) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-90232 | Film No.: 25958891
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)